Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.12 AUD 9.09% Market Closed
Market Cap: 16.2m AUD
Have any thoughts about
Star Combo Pharma Ltd?
Write Note

Star Combo Pharma Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Star Combo Pharma Ltd
Revenue Peer Comparison

Comparables:
BXN
MCP
EXL
B
BIO
H
HPC

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Star Combo Pharma Ltd
ASX:S66
Revenue
AU$26.3m
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Bioxyne Ltd
ASX:BXN
Revenue
AU$9.3m
CAGR 3-Years
64%
CAGR 5-Years
34%
CAGR 10-Years
15%
McPherson's Ltd
ASX:MCP
Revenue
AU$144.7m
CAGR 3-Years
-10%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Elixinol Wellness Ltd
ASX:EXL
Revenue
AU$8.5m
CAGR 3-Years
-18%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
B
Biome Australia Ltd
ASX:BIO
Revenue
AU$13.4m
CAGR 3-Years
72%
CAGR 5-Years
103%
CAGR 10-Years
N/A
H
Hydration Pharmaceuticals Co Ltd
ASX:HPC
Revenue
$10m
CAGR 3-Years
39%
CAGR 5-Years
19%
CAGR 10-Years
N/A

See Also

What is Star Combo Pharma Ltd's Revenue?
Revenue
26.3m AUD

Based on the financial report for Jun 30, 2024, Star Combo Pharma Ltd's Revenue amounts to 26.3m AUD.

What is Star Combo Pharma Ltd's Revenue growth rate?
Revenue CAGR 5Y
4%

Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Star Combo Pharma Ltd have been -1% over the past three years , 4% over the past five years .

Back to Top